Surface expression and release of soluble forms of CD8 and CD23 in CD40- and IL-4-activated mononuclear cells from patients with Graves' disease (GD).
We investigated the effect of T cell-dependent B cell activation on the surface expression and release of the soluble forms of CD8 and CD23 by peripheral blood mononuclear cells (PBMC) obtained from patients with GD, versus patients with Hashimoto's thyroiditis, and normal controls. Incubating the PBMC with anti-CD40 MoAbs and IL-4 increased the soluble CD23 levels in cells from all three groups. An increase in the number of CD23+ cells was observed in the PBMC from the patients with GD, but not in PBMC from Hashimoto's thyroiditis or controls. Less soluble CD8 was released from anti-CD40 antibody and IL-4-stimulated PBMC obtained from patients with GD relative to those from the controls. In addition, the number of CD8+ cells was significantly reduced in stimulated PBMC from the GD patients relative to those from controls. Incubation of PBMC with anti-CD40 antibody plus IL-4 did not affect the proportions of CD4+, CD20+, Fas+ CD4+, and Fas+ CD8+ cells. The addition of T3 to cultured PBMC from controls did not reproduce the changes in CD23+ and CD8+ cells noted in the samples froin GD patients. Thus, T cell-dependent B cell activation, mediated by a CD40 pathway, may reduce the number of CD8+ cells, causing exacerbation of GD.
Department of Internal Medicine, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
M
M
Itoh
K
K
Uchimura
N
N
Hayakawa
M
M
Makino
R
R
Hayashi
M
M
Nagata
H
H
Kakizawa
A
A
Nagasaka
H
H
Sakamoto
H
H
Kuzuya
D000328:Adult; D001402:B-Lymphocytes / Q000276:immunology; D019013:CD40 Antigens / Q000276:immunology*; D016827:CD8 Antigens / Q000096:biosynthesis*; D005260:Female; D006111:Graves Disease / Q000276:immunology*; D006801:Humans; D015847:Interleukin-4 / Q000494:pharmacology*; D007963:Leukocytes, Mononuclear / Q000187:drug effects / Q000276:immunology*; D008213:Lymphocyte Activation; D008297:Male; D008875:Middle Aged; D017455:Receptors, IgE / Q000096:biosynthesis*; D012995:Solubility; D013601:T-Lymphocytes / Q000276:immunology; D013967:Thyroiditis, Autoimmune / Q000276:immunology; D014284:Triiodothyronine / Q000494:pharmacology
D019013:CD40 Antigens; D016827:CD8 Antigens; D017455:Receptors, IgE; D014284:Triiodothyronine; D015847:Interleukin-4